SCHEMBL6407655

SCHEMBL6407655

O=C1C=CC(=O)c2[nH]c(=O)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.54
TDP2 O95551 2/20 0.47
NSD2 O96028 1/20 0.47
CDC25B P30305 3/20 0.40
PIN1 Q13526 2/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
AKT1 P31749 1/20 0.40
SNCA P37840 1/20 0.40
MAP2K1 Q02750 1/20 0.40
EHMT2 Q96KQ7 1/20 0.40
NSD1 Q96L73 1/20 0.40
EHMT1 Q9H9B1 1/20 0.40
CTH P32929 1/20 0.40
S100A4 P26447 2/20 0.34
ALDH1A1 P00352 2/20 0.33
AOC3 Q16853 1/20 0.33
CDC25A P30304 3/20 0.33
CDC25C P30307 3/20 0.33
CA12 O43570 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16416442 0.76 IDO1 (0.40) IDO1TDP2NSD2CDC25BPIN1
SCHEMBL6269145 0.70 TDP2 (0.55) IDO1TDP2NSD2CDC25BMAOA
SCHEMBL1650480 0.70 IDO1 (1.00) IDO1CDC25BPIN1MAOAMAOB
SCHEMBL12390669 0.65 IDO1 (0.41) IDO1CDC25BPIN1MAOAMAOB
SCHEMBL2922398 0.64 PDE10A (0.52) ALDH1A1KDM4EHPGDMAPK1HSD17B10
SCHEMBL7830760 0.62 ALDH1A1 (0.44) IDO1CDC25BPIN1MAOAMAOB
SCHEMBL7443013 0.61 ALOX15 (0.48) IDO1ALDH1A1KDM4EMEN1MAPT
SCHEMBL3958516 0.59 IDO1 (0.44) IDO1CDC25BPIN1MAOAMAOB
Naphthoquinone SCHEMBL29354680 0.58 IDO1 (1.00) IDO1TDP2CDC25BPIN1MAOA
SCHEMBL16736421 0.58 CA12 (0.55) ALDH1A1AOC3CA12CA1CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118903118-A Use of 3-substituted naphtho [2,3-b ] isoxazole-4, 9-dione derivatives for anti-psoriasis 中南大学 2024-11-08 CN disclosed
EP-1202993-B1 PHENANTHROLINE-7-ONE DERIVATIVES AND THEIR THERAPEUTIC USES LAFON LABOR (FR) 2005-10-19 EP disclosed
US-6809096-B1 SUCH AS 11-METHOXY-7H-PYRIDO(4,3,2-DE)(1,7)PHENANTHROLINE-7-ONE; ANTITUMOR AGENTS LABORATOIRE L. LAFON (FR) 2004-10-26 US disclosed
US-6583150-B1 Cytotoxic propertie; antitumor; pyrido-(3,2-g)quinoline-5,10-diones; benzo(b)pyrido(4,3,2-de)(1,7)-phenanthroline-8-ones LABORATORIE L. LAFON (FR) 2003-06-24 US disclosed
US-6515127-B1 The invention concerns a method for preparing quinoline-5,8-diones of formula (I) light-induced oxygenation of a 8-hydroxyquinoline. and intermediates LABORATOIRE L. LAFON (FR) 2003-02-04 US disclosed
EP-1202993-A2 PHENANTHROLINE-7-ONE DERIVATIVES AND THEIR THERAPEUTIC USES LABORATOIRE L. LAFON (FR) 2002-05-08 EP disclosed
EP-1161432-A1 PHARMACEUTICAL COMPOSITION BASED ON POLYAROMATIC COMPOUNDS LABORATOIRE L. LAFON (FR) 2001-12-12 EP disclosed
WO-2001012632-A2 PHENANTHROLINE-7-ONE DERIVATIVES AND THEIR THERAPEUTIC USES LABORATOIRE L. LAFON (FR) 2001-02-22 WO disclosed
WO-2000055160-A1 PHARMACEUTICAL COMPOSITION BASED ON POLYAROMATIC COMPOUNDS LABORATOIRE L. LAFON (FR) 2000-09-21 WO disclosed